1. Home
  2. RGNX vs GNTY Comparison

RGNX vs GNTY Comparison

Compare RGNX & GNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • GNTY
  • Stock Information
  • Founded
  • RGNX 2008
  • GNTY 1913
  • Country
  • RGNX United States
  • GNTY United States
  • Employees
  • RGNX N/A
  • GNTY N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • GNTY Major Banks
  • Sector
  • RGNX Health Care
  • GNTY Finance
  • Exchange
  • RGNX Nasdaq
  • GNTY Nasdaq
  • Market Cap
  • RGNX 445.5M
  • GNTY 520.5M
  • IPO Year
  • RGNX 2015
  • GNTY 2017
  • Fundamental
  • Price
  • RGNX $8.82
  • GNTY $48.63
  • Analyst Decision
  • RGNX Strong Buy
  • GNTY Buy
  • Analyst Count
  • RGNX 8
  • GNTY 2
  • Target Price
  • RGNX $28.50
  • GNTY $44.50
  • AVG Volume (30 Days)
  • RGNX 687.5K
  • GNTY 45.5K
  • Earning Date
  • RGNX 08-07-2025
  • GNTY 10-20-2025
  • Dividend Yield
  • RGNX N/A
  • GNTY 2.06%
  • EPS Growth
  • RGNX N/A
  • GNTY 38.57
  • EPS
  • RGNX N/A
  • GNTY 3.15
  • Revenue
  • RGNX $155,782,000.00
  • GNTY $127,325,000.00
  • Revenue This Year
  • RGNX $327.08
  • GNTY $10.99
  • Revenue Next Year
  • RGNX N/A
  • GNTY $4.83
  • P/E Ratio
  • RGNX N/A
  • GNTY $15.43
  • Revenue Growth
  • RGNX 74.95
  • GNTY 10.12
  • 52 Week Low
  • RGNX $5.04
  • GNTY $32.04
  • 52 Week High
  • RGNX $13.48
  • GNTY $49.02
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 53.29
  • GNTY 65.32
  • Support Level
  • RGNX $7.83
  • GNTY $45.22
  • Resistance Level
  • RGNX $9.24
  • GNTY $48.60
  • Average True Range (ATR)
  • RGNX 0.51
  • GNTY 0.91
  • MACD
  • RGNX 0.08
  • GNTY 0.35
  • Stochastic Oscillator
  • RGNX 77.37
  • GNTY 93.07

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

Share on Social Networks: